Risk of Cardiorespiratory Events Following Respiratory Syncytial Virus–Related Hospitalization
This study demonstrated that RSV, similar to influenza and SARS-CoV-2, was associated with an increased risk of cardiorespiratory events 2 weeks following RSV-related hospitalization, and some conditions had significant risk elevations up to 180 days after admission. The findings reinforce the need to increase RSV immunization in adults.
Authors
- Jennifer Judy (ORCID: https://orcid.org/0000-0002-2246-9745)
- Negar Aliabadi (ORCID: https://orcid.org/0000-0002-9264-5089)
- Erica Chilson (ORCID: https://orcid.org/0000-0002-4417-3398)
- Caihua Liang
- Xin Zhao
- Yun Zhou
- Bradford D. Gessner
- Reiko Sato
- Elizabeth Begier
Institutions
- Pfizer (United States) (US)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Pfizer (Ireland) (IE)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.56767
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer